Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Top Cited Papers
Open Access
- 18 March 2020
- journal article
- letter
- Published by Springer Nature in Cell Discovery
- Vol. 6 (1), 1-4
- https://doi.org/10.1038/s41421-020-0156-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- First Case of 2019 Novel Coronavirus in the United StatesNew England Journal of Medicine, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusionAutophagy, 2018
- Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1 + Endolysosomes Is a Rate-Defining StepJournal of Virology, 2015
- Effect of Phospholipidosis on the Cellular Pharmacokinetics of ChloroquineJournal of Pharmacology and Experimental Therapeutics, 2010
- New insights into the antiviral effects of chloroquineThe Lancet Infectious Diseases, 2006
- Animal toxicity and pharmacokinetics of hydroxychloroquine sulfateThe American Journal of Medicine, 1983
- Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.Proceedings of the National Academy of Sciences, 1978
- CHLOROQUINE: A REVIEWRheumatology, 1976
- Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and HydroxychloroquineScandinavian Journal of Rheumatology, 1974